Cell-Dissociation Market Share in 2023 | Saloni Manchanda posted on the topic | LinkedIn (2025)

Biotechnology Contract Manufacturing Market Estimated to Reach $24.8 Billion by 2028𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dJJhV-tGThe global #biotechnology #contractmanufacturing market, in terms of revenue, was estimated to be worth $16.6 billion in 2023 and is poised to reach $24.8 billion by 2028, growing at a CAGR of 8.3% from 2023 to 2028.Wheeler Bio, Inc.NunaBio LimitedAtomVie Global Radiopharma Inc.Kindeva Drug DeliveryPlanetaryGenScript ProBioInno BioScience Exothera ViroCell BiologicsVictoGen PharmaPfizer CentreOneCritiTech Particle Engineering SolutionsMEMStimKBioCatalent Pharma SolutionsNorthway BiotechCambrexResilienceNew Health Sciences (NHS) ManufacturingParimer ScientificPatheonAvema Pharma SolutionsNephron PharmaceuticalsBaxter International Inc.CellVec Pte LtdEsco VacciXcellGenesis Medtech GroupFUJIFILM Diosynth BiotechnologiesCambrexCellin TechnologiesBioSpectra, Inc.AGC BiologicsAltasciencesAvema Pharma SolutionsDipharma Francis S.r.lMiltenyi BiotecElevateBioLandmark Bio

3

CellRev have been working with C2C12 cells for several years now in an effort to demonstrate true continuous processing of adherent cells.Read our case study to understand how we are facilitating the transition to continuous processing. https://hubs.ly/Q02c-y-H0We have now shown compatibility with several cell lines including VERO Cells, iPSCs, and Fibroblasts.Get in touch on enquiry@cellrev.co.uk to discuss your requirements#cellmanufacturing #celltherapy #biomanufacturing #cellculture #bioprocessing #processautomation #biosciences #biotechnology #biopharma #pharma #biotech #innovation #biotechnology #bioengineering

7

ARTICLE | Our latest research in 𝗔𝗖𝗦 𝗢𝗺𝗲𝗴𝗮, prepared in collaboration with DTU - Technical University of Denmark, introduces 𝗚𝗔𝗦𝗣, a novel data-driven approach for pinpointing the best enzyme-catalyzed glycosylation reactions. 👉 GASP uses machine learning to identify the right enzyme for the job, solving common issues like stereochemistry, regioselectivity, and solubility. With an accuracy of 72%, it's a powerful solution for the biotech and pharmaceutical industries. 👉 GASP has been tested on two real-world case studies and it outperformed a random selection assay by 30%! Plus, it's easy to use.Check out our study to learn more about GASP:https://lnkd.in/eGQ4sUJF #enzyme #glycosylation #biotech #pharmaceuticals #machinelearning

4

Attending American Association of Pharmaceutical Scientists (AAPS) | @aapscomms Summer Scientific Forum in Kansas City? Stop by and talk to our experts, Manny Lozano and Robert Durham. Let us show you how to accelerate biotherapeutics development with 1-hour automated microfluidic immunoassays. Improve assay dynamic range, data quality, and sensitivity while saving time and sample.#Gyrolab #biotechnology #immunoassay #bioanalysis

34

𝐇𝐢𝐠𝐡-𝐓𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 (𝐇𝐓𝐒) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟓𝟎.𝟐 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆>>https://bit.ly/4d13NWSThe global #high_throughput_screening (HTS) market is projected to reach USD 50.2 billion by 2029 from USD 28.8 billion in 2024, at a CAGR of 11.8% during the forecast period.𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐰𝐚𝐬 𝐭𝐡𝐞 𝐥𝐚𝐫𝐠𝐞𝐬𝐭 𝐫𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐟𝐨𝐫 𝐡𝐢𝐠𝐡-𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐢𝐧 𝟐𝟎𝟐𝟑.In 2023, North America accounted for the largest share of the high-throughput screening market, followed by Europe and the Asia Pacific. The large share of the North American high throughput screening (HTS) market can be attributed to factors such as the rising cases of #diseases in the region which is leading to a rise in #pharmaceutical research and development (R&D) activities and funding to support #drugdiscovery and development. The presence of major pharmaceutical and #biotechnology companies in the region further supports the large share of the North American high throughput screening (HTS) market.𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:Thermo Fisher Scientific, Agilent Technologies, Merck, Danaher Corporation, Revvity , Tecan, Bio-Rad Laboratories, Corning Incorporated, Mettler-Toledo International, Inc, Lonza, Waters Corporation, Sartorius, Eppendorf , Porvair plc, Charles River Laboratories, Eurofins Scientific Finland Oy, Hamilton Company, Aurora Biomed Inc., Gilson, BRAND GMBH + CO KG, BMG LABTECH, DIANA Biotechnologies, Creative Biolabs, HighRes Biosolutions, , AXXAM SERVICES, Sygnature Discovery, Crown Bioscience#HighThroughputScreening #HTS #DrugDiscovery #Biotech #Pharma #LaboratoryAutomation #HTSTechnology #ScreeningAssays #Bioinformatics #HTSResearch

I liked how we said, 'Discover the future of biophysical characterization,' for RNA/DNA and LNP. Yes, our customers have been amazed by how much they could learn from MMS spectra that no other tools could provide. But for proteins/peptides, it’s not the 'future' anymore, as companies are filing MMS for IND, and CDMOs are using it for clients.Can’t wait to chat more with you! Mark it down - Booth 313!

6

Single Use Bioreactors Market worth $10.0 billion𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dTvg9um2The global single use bioreactors market is projected to reach USD 10.0 billion by 2028 from USD 4.2 billion in 2023, at a CAGR of 19.0% during the forecast period of 2023 to 2028.The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.#SingleUse #bioreactors #Biomanufacturing #pharmaceutical #biopharmaceutical #biotechnologySartoriusDanaher CorporationThermo Fisher ScientificMerck KGaA, Darmstadt, GermanyGetingeEppendorf GroupEntegrisAvantorCorning IncorporatedEscoKuhner shakerTECNICPBS BiotechSatake CorporationABECbbi-biotech GmbHREPROCELLCellexusDistek, Inc.OmniBRx Biotechnologies Pvt LtdNew Horizon BiotechGPC Bio USAMeissnerCell Culture CompanyAUCTEQ Biosystems GmbH

Bioburden control during processing of biologics has become more relevant than ever due to the growing trend of integrated continuous bioprocessing. The #IntuGrow technology was developed to measure in complex matrices, making it ideal for in-process control of these types of bioprocessing lines with results down to 3 hours.Learn more: https://intubio.dk/Any questions? Reach out to: contact@intubio.dk#bioburden #ICB #bioprocessing #inprocesscontrol #microbiology

20

Lexaria Bioscience CEO Chris Bunka joined Steve Darling from Proactive to share significant updates regarding its focus on DehydraTECH, a patented drug delivery formulation and processing platform technology aimed at improving the oral delivery of active pharmaceutical ingredients. Lexaria BioScience has initiated its second DehydraTECH-powered glucagon-like peptide 1 (GLP-1) human pilot study.This randomized, crossover, placebo-controlled investigation will compare three dose formulations, each containing a 7 mg dose of semaglutide Semaglutide, when swallowed into the stomach or intestine without the aid of absorption technology, typically exhibits a low absorption rate, typically less than 1%. This low absorption is attributed, in part, to the acidic environment of the stomach, which can degrade GLP-1 drug. Watch at #Proactive #ProactiveInvestors #NASDAQ #LEXX http://ow.ly/zN4m105mpyq

HaLCon provides the simplest, fastest, protein concentration measurements – straight from a bioreactor.HaLCon provides real-time antibody concentrations, with all the accuracy, but none of the complexity of HPLC-protein A analysis.HaLCon is now completely automated, introducing the Nest Autosampler!With HaLCon+Nest you can analyze up to 192-samples in one run completely hands-free, analysis time is 5 minutes/sample, and with the simple touchscreen interface it takes less than 15 minutes to train new users.Attending The Bioprocessing Summit in Boston?Stop by booth 615 and see the HaLCon + Nest Autosampler.On Wednesday August 21st in the Next Generation Analytical Methods track, hear Yuxiang (Henry) Zhao from Bristol Myers Squibb present a talk entitled:HaLCon Protein Analyzer: A Study on At-Line Titer Analysis in Biopharmaceutical Applications.Additionally, a poster entitled: A comparative study to evaluate different analytical methods used to quantify a fusion protein and two types of IgG molecules produced in CHO cell line, will be presented by Nida Sayed Zubairy from Boston Institute of Biotechnology.https://lnkd.in/ef-WV6uk#bioprocessing #innovation #monoclonalantibodies #mabs #bioproduction #protein #upstream #downstreamprocessing #cdmo #bioreactor #efficiency #biobusiness #biotherapeutics #hplc #automation #autosampler

3